Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Operating Leases (2019 - 2024)

Historic Operating Leases for Cresco Labs (CRLBF) over the last 4 years, with Q3 2024 value amounting to $157.7 million.

  • Cresco Labs' Operating Leases changed N/A to $157.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $157.7 million, marking a year-over-year change of. This contributed to the annual value of $163.8 million for FY2023, which is 550.0% down from last year.
  • Latest data reveals that Cresco Labs reported Operating Leases of $157.7 million as of Q3 2024.
  • Cresco Labs' Operating Leases' 5-year high stood at $173.3 million during Q4 2022, with a 5-year trough of $124.1 million in Q1 2022.
  • For the 3-year period, Cresco Labs' Operating Leases averaged around $157.1 million, with its median value being $161.9 million (2024).
  • Over the last 5 years, Cresco Labs' Operating Leases had its largest YoY gain of 550.0% in 2023, and its largest YoY loss of 550.0% in 2023.
  • Cresco Labs' Operating Leases (Quarter) stood at $173.3 million in 2022, then dropped by 5.5% to $163.8 million in 2023, then fell by 3.74% to $157.7 million in 2024.
  • Its Operating Leases stands at $157.7 million for Q3 2024, versus $160.5 million for Q2 2024 and $163.3 million for Q1 2024.